Cytosorbents Corp Annual Operating Lease, Payments in USD from 2017 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Cytosorbents Corp quarterly/annual Operating Lease, Payments history and growth rate from 2017 to 2024.
  • Cytosorbents Corp Operating Lease, Payments for the quarter ending December 31, 2024 was $18.5K, a 97.2% decline year-over-year.
  • Cytosorbents Corp Operating Lease, Payments for the twelve months ending December 31, 2024 was $1.68M, a 29.9% decline year-over-year.
  • Cytosorbents Corp annual Operating Lease, Payments for 2024 was $1.68M, a 29.9% decline from 2023.
  • Cytosorbents Corp annual Operating Lease, Payments for 2023 was $2.4M, a 18.1% decline from 2022.
  • Cytosorbents Corp annual Operating Lease, Payments for 2022 was $2.94M, a 49.1% increase from 2021.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $1.68M -$720K -29.9% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-31
2023 $2.4M -$532K -18.1% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-31
2022 $2.94M +$967K +49.1% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-15
2021 $1.97M +$1.03M +110% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-15
2020 $937K +$31K +3.42% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-09
2019 $906K +$101K +12.5% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-10
2018 $805K +$129K +19.1% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-09
2017 $676K Jan 1, 2017 Dec 31, 2017 10-K 2020-03-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.